STOCK TITAN

HIVE Announces Upsizing and Pricing of Private Offering of US$115 Million of 0% Exchangeable Senior Notes due 2031

(Neutral)
(Neutral)
Tags
private placement offering

HIVE (NASDAQ:HIVE) priced an upsized private offering of US$115 million 0% exchangeable senior notes due 2031 through subsidiary HIVE Bermuda 2026. Initial purchasers have a US$15 million option. Notes are exchangeable into HIVE common shares at an initial price of US$4.83 per share.

Estimated net proceeds are US$110 million (or US$124.5 million if the option is fully exercised), earmarked for general corporate purposes, capital investment, and data center development. HIVE also entered capped call transactions with an initial cap price of US$8.5275 per share.

Loading...
Loading translation...

Positive

  • Offering upsized to US$115 million 0% exchangeable senior notes due 2031
  • Initial purchasers' option for up to US$15 million additional notes
  • Estimated net proceeds of US$110 million, or US$124.5 million with full option exercise
  • Exchange price set at US$4.83 per share, about 27.5% above last Nasdaq close
  • Capped call transactions with initial cap at US$8.5275 per share to reduce dilution risk

Negative

  • Exchangeable structure may result in future share dilution upon note exchanges
  • Holders can require cash repurchase of notes on July 1, 2030 at principal
  • Fundamental change events trigger 100% principal cash repurchase obligation
  • Hedging and derivative activity by option counterparties may impact HIVE share and note prices

News Market Reaction – HIVE

+6.33% 1.6x vol
48 alerts
+6.33% Session close to close
+5.3% Peak Tracked
-19.2% Trough Tracked
$1.13B Market Cap
1.6x Rel. Volume

In the Jun 26 session, HIVE gained 6.33%, reflecting a notable positive market reaction. Argus tracked a peak move of +5.3% during that session. Argus tracked a trough of -19.2% from its starting point during tracking. Our momentum scanner triggered 48 alerts that day, indicating elevated trading interest and price volatility. Trading volume was above average at 1.6x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +6.3% in the session following this news. A strong positive reaction aligns with HIV...
Analysis

The stock moved +6.3% in the session following this news. A strong positive reaction aligns with HIVE’s history of upbeat responses to strategic financing and expansion news. The upsized US$115 million 0% exchangeable notes and capped calls add growth capital while partially addressing dilution risk.

Key Figures

Exchangeable notes size: US$115 million aggregate principal amount Upsize from prior plan: US$100 million to US$115 million Initial purchasers’ option: Up to US$15 million additional notes +5 more
8 metrics
Exchangeable notes size US$115 million aggregate principal amount 0% exchangeable senior notes due 2031 private offering
Upsize from prior plan US$100 million to US$115 million Aggregate principal amount increased versus earlier announcement
Initial purchasers’ option Up to US$15 million additional notes Option exercisable within 13 days of initial issuance
Initial exchange rate 206.9429 Common Shares per US$1,000 notes Equates to initial exchange price of about US$4.83 per share
Initial exchange price US$4.83 per Common Share (27.5% premium) Premium to US$3.79 Nasdaq closing price on June 25, 2026
Estimated net proceeds Approximately US$110.0 million Net of discounts and expenses; before any option exercise
Capped call cap price US$8.5275 per Common Share (125.0% premium) Cap level for cash-settled capped call transactions
Redemption trigger level 130% of exchange price Share price condition for issuer-optional redemption after July 5, 2029

Historical Context

5 past events · Latest: Jun 22 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jun 22 AI infrastructure study Positive +16.6% Columbia study validated Paraguay AI GPU performance and supported Gigafactory plans.
Jun 22 AI performance results Positive +16.6% AI benchmarks showed A40 GPUs matching normalized H100 performance for select workloads.
Jun 18 Sovereign AI GPU contract Positive +9.2% Three-year USD $220m sovereign AI GPU cloud contract via BUZZ HPC subsidiary.
Jun 18 AI partnership announcement Positive +9.2% Partnership announcement supporting sovereign AI infrastructure in Canada with key partners.
Jun 18 Data center acquisition Positive +9.2% Approval to acquire 32 MW Big Boden data center to expand AI and HPC capacity.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent AI and infrastructure announcements have coincided with strong positive price reactions, suggesting investors have rewarded growth- and contract-related news.

Key Terms

exchangeable senior notes, rule 144a, capped call transactions, fundamental change
4 terms
exchangeable senior notes financial
"US$115 million aggregate principal amount of 0% exchangeable senior notes due 2031"
Exchangeable senior notes are loans a company issues that promise regular interest payments and have priority over other debts, but can be swapped by the holder for shares of a different company. Think of it as lending money with an option to trade the loan for someone else’s stock; investors weigh the steady income and higher repayment priority against the chance of receiving shares that dilute ownership or fluctuate in value. These features affect a company’s credit risk, potential dilution, and appeal to different investors.
rule 144a regulatory
"pursuant to Rule 144A under the Securities Act of 1933"
Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.
capped call transactions financial
"the Company entered into privately negotiated cash-settled capped call transactions"
Capped call transactions are agreements where investors buy options that give them the chance to benefit if a stock's price goes up, but with a limit on how much they can gain. This helps protect them from paying too much if the stock's price rises a lot, similar to having a maximum limit on a reward. They matter because they help investors manage risk while still allowing some upside potential.
fundamental change financial
"If HIVE undergoes a "fundamental change," subject to certain conditions and limited exceptions"
A fundamental change is a major shift in how a company or economy operates, like a new technology or a big change in leadership. It matters because such changes can affect the value or stability of investments, making them more or less attractive. Think of it like a major upgrade or shift in the rules of a game that can change the outcome.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated June 16, 2026 to its short form base shelf prospectus dated October 31, 2025.

San Antonio, Texas--(Newsfile Corp. - June 25, 2026) - HIVE Digital Technologies Ltd. (TSX: HIVE) (NASDAQ: HIVE) (BVC: HIVECO) (the "Company" or "HIVE") today announced the pricing of US$115 million aggregate principal amount of 0% exchangeable senior notes due 2031 (the "Notes") in a private offering (the "Offering") by HIVE Bermuda 2026 Ltd., its wholly-owned subsidiary (the "Issuer"), to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The aggregate principal amount of the Notes to be issued in the Offering was increased to US$115 million from the previously announced US$100 million. The Issuer also granted the initial purchasers of the Notes an option, exercisable within a period of 13 days from and including the date the Notes are first issued, to purchase up to an additional US$15 million aggregate principal amount of Notes (the "Option"). The sale of the Notes is expected to close on June 30, 2026, subject to customary closing conditions.

The Notes will be general unsecured obligations of the Issuer. The Issuer's obligations under the Notes will be fully and unconditionally guaranteed on a senior unsecured basis by HIVE. The Notes will not bear regular interest, and the principal amount of the Notes will not accrete. The Notes will mature on July 1, 2031, unless earlier exchanged, redeemed or repurchased. Prior to April 1, 2031, the Notes will be exchangeable only upon satisfaction of certain conditions and during certain periods, and thereafter, at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. The Issuer will settle exchanges by paying or delivering, as the case may be, cash, common shares of HIVE ("Common Shares") or a combination of cash and Common Shares, at the Issuer's election. The initial exchange rate will be 206.9429 Common Shares per US$1,000 principal amount of Notes (equivalent to an initial exchange price of approximately US$4.83 per Common Share, which represents a premium of approximately 27.5% above the closing sale price per Common Share on the Nasdaq Capital Market ("Nasdaq") on June 25, 2026), subject to adjustment in some events.

The Issuer may only redeem the Notes prior to July 5, 2029 at its option, in whole but not in part, upon the occurrence of certain tax-related events. The Issuer also may redeem the Notes at its option on or after July 5, 2029 in whole or in part if the last reported sale price of the Common Shares has been at least 130% of the exchange price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Issuer provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date.

Holders of the Notes may require the Issuer to repurchase for cash all or any portion of their Notes on July 1, 2030, at a cash repurchase price equal to the principal amount of the Notes to be repurchased. If HIVE undergoes a "fundamental change," subject to certain conditions and limited exceptions, holders of the Notes may require the Issuer to repurchase for cash all or any portion of their Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, following certain corporate events that occur prior to the maturity date of the Notes or upon the Issuer's issuance of a notice of redemption, the Issuer will, in certain circumstances, increase the exchange rate for holders of the Notes who elect to exchange their Notes in connection with such a corporate event or exchange their Notes called (or deemed called) for redemption during the related redemption period, as the case may be.

The Issuer estimates that the net proceeds from the Offering will be approximately US$110.0 million (or approximately US$124.5 million if the initial purchasers exercise the Option in full), after deducting the initial purchasers' estimated discounts and commissions and estimated offering expenses payable by the Issuer.

The Issuer intends to use the net proceeds from the Offering to fund one or more of HIVE's direct or indirect subsidiaries, or to make a capital contribution to any such subsidiary or subsidiaries, which in turn will use such proceeds for general corporate purposes, capital investment (including, but not limited to, the purchase of graphics processing units) and data center development. HIVE intends to fund capped call transactions (as described below) using cash on hand, and the Issuer may use a portion of the net proceeds to reimburse HIVE for the cost of the capped call transactions. If the initial purchasers exercise the Option, the Issuer intends to use the net proceeds from the sale of the additional Notes to fund one or more of HIVE's direct or indirect subsidiaries, which in turn will use such proceeds for general corporate purposes, capital investment (as described above) and data center development, and the Issuer may use a portion of the net proceeds to reimburse HIVE for the cost of entering into additional capped call transactions, as described below.

In connection with the Offering, the Company entered into privately negotiated cash-settled capped call transactions with certain financial institutions (collectively, the "option counterparties"). The cap price of the capped call transactions is initially US$8.5275 per Common Share, which represents a premium of 125.0% to the last reported sale price of US$3.79 per Common Share on the Nasdaq on June 25, 2026. The capped call transactions will be subject to anti-dilution adjustments substantially similar to those applicable to the Notes.

The capped call transactions are expected generally to reduce potential economic dilution of the Common Shares upon exchange of any Notes and/or offset any cash payments the Issuer could be required to make in excess of the principal amount of exchanged Notes, as the case may be, with such reduction and/or offset subject to a cap. If the initial purchasers exercise the Option, the Company expects to enter into additional capped call transactions with the option counterparties.

In connection with establishing their initial hedges of the capped call transactions, the Company expects the option counterparties or their respective affiliates to purchase Common Shares and/or enter into various derivative transactions with respect to the Common Shares concurrently with or shortly after the pricing of the Notes, and such option counterparties or their respective affiliates may unwind these various derivative transactions and/or sell Common Shares in open market transactions. This activity could increase (or reduce the size of any decrease in) the market price of the Common Shares or the Notes at that time. In addition, the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to the Common Shares and/or purchasing or selling Common Shares or other securities of the Company in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so during any observation period related to an exchange of the Notes). This activity could also cause or avoid an increase or decrease in the market price of the Common Shares or the Notes, which could affect holders of the Notes' ability to exchange the Notes and, to the extent the activity occurs during any observation period related to an exchange of the Notes, it could affect the amount and value of the consideration that holders of the Notes will receive upon exchange of such Notes.

The Company is relying on the exemption under Section 602.1 of the TSX's Company Manual (the "TSX Manual") available to Eligible Interlisted Issuers (as defined in the TSX Manual) in respect of the Offering.

None of the Notes, the guarantee or the Common Shares issuable upon exchange of the Notes, if any, have been, and will not be, registered under the Securities Act or the securities laws of any other jurisdiction, and, unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About HIVE Digital Technologies Ltd.

Founded in 2017, HIVE Digital Technologies Ltd. was among the first publicly listed companies to prioritize mining digital assets powered by green energy. Today, HIVE builds and operates next-generation Tier-I and Tier-III data centers across Canada, Sweden, and Paraguay, serving both Bitcoin and high-performance computing clients. HIVE's dual engine infrastructure, driven by hashrate services and GPU-accelerated AI computing, delivers scalable, environmentally responsible solutions for the digital economy.

For more information, visit hivedigitaltech.com, or connect with us on:

X: https://x.com/HIVEDigitalTech
YouTube: https://www.youtube.com/@HIVEDigitalTech
Instagram: https://www.instagram.com/hivedigitaltechnologies/
LinkedIn: https://linkedin.com/company/hiveblockchain

On Behalf of HIVE Digital Technologies Ltd.

"Frank Holmes"
Executive Chairman

For further information, please contact:

Nathan Fast, Director of Marketing and Branding
Frank Holmes, Executive Chairman
Aydin Kilic, President & CEO

Tel: (604) 664-1078

Neither the TSX, Nasdaq, nor any other securities exchange or regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

This news release contains "forward-looking information" within the meaning of the applicable Canadian and United States securities legislation and regulations that is based on expectations, estimates and projections as at the date of this news release. "Forward-looking information" in this news release includes but is not limited to: statements with respect to the closing of the Offering, the potential issuance of additional Notes pursuant to the Option, the use of proceeds from the Offering (including the payment of costs associated with the capped call transactions), business goals and objectives of the Company, and other forward-looking information concerning the intentions, plans and future actions of the Company and the terms of the transaction described herein.

The forward-looking information in this news release reflects the Company's current expectations, assumptions, and/or beliefs based on information currently available to the Company. In connection with the forward-looking information contained in this news release, the Company has made assumptions about the Company's objectives, goals or future plans, the timing thereof and related matters. The Company has also assumed that no significant events occur outside of the Company's normal course of business. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance, and accordingly, undue reliance should not be put on such information due to its inherent uncertainty. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, other than as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302967

FAQ

What are the key terms of HIVE (NASDAQ:HIVE) US$115 million 0% exchangeable senior notes due 2031?

The notes are 0% exchangeable senior notes maturing July 1, 2031, issued in a US$115 million private offering. According to HIVE, they are unsecured, guaranteed by HIVE, and exchangeable into common shares at an initial price of about US$4.83 per share.

How much capital will HIVE raise from the US$115 million exchangeable notes offering?

HIVE expects net proceeds of about US$110 million from the base offering. According to HIVE, proceeds could reach approximately US$124.5 million if initial purchasers fully exercise the additional US$15 million option, after discounts, commissions, and expenses.

What will HIVE use the net proceeds from the HIVE (HIVE) exchangeable notes for?

Net proceeds will fund HIVE subsidiaries for general corporate purposes, capital investment, and data center development. According to HIVE, investments may include purchasing graphics processing units, and some proceeds may reimburse HIVE for capped call transaction costs.

How does the exchange feature work on HIVE’s 0% senior notes due 2031?

The notes are initially exchangeable at 206.9429 HIVE shares per US$1,000 principal, equal to US$4.83 per share. According to HIVE, exchanges may be settled in cash, shares, or both, with certain conditions before April 1, 2031 and anytime thereafter until maturity.

What redemption and repurchase rights apply to HIVE (NASDAQ:HIVE) exchangeable notes?

Holders may require cash repurchase on July 1, 2030 at principal and upon certain fundamental changes. According to HIVE, the issuer may redeem notes after July 5, 2029 if share prices reach at least 130% of the then-current exchange price for specified periods.

Could hedging activity from the capped call counterparties affect HIVE (HIVE) stock price?

Yes. Option counterparties may buy or sell HIVE shares and derivatives to hedge the capped calls. According to HIVE, this activity could increase or reduce the size of price moves in HIVE shares or the notes, including during observation periods around note exchanges.